California State Teachers Retirement System (CalSTRS)’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.65K Sell
8,316
-1,142
-12% -$1.32K ﹤0.01% 2805
2025
Q4
$12.3K Buy
9,458
+943
+11% +$1.16K ﹤0.01% 2715
2025
Q3
$10.7K Buy
8,515
+8
+0.1% +$13 ﹤0.01% 2810
2025
Q2
$17.6K Hold
8,507
﹤0.01% 2533
2025
Q1
$18.7K Hold
8,507
﹤0.01% 2548
2024
Q4
$13K Hold
8,507
﹤0.01% 2763
2024
Q3
$16.9K Hold
8,507
﹤0.01% 2674
2024
Q2
$29.8K Sell
8,507
-1,902
-18% -$5.84K ﹤0.01% 2486
2024
Q1
$28.8K Sell
10,409
-6,634
-39% -$16.7K ﹤0.01% 2596
2023
Q4
$29K Sell
17,043
-5,804
-25% -$6.39K ﹤0.01% 2801
2023
Q3
$23.5K Sell
22,847
-11,597
-34% -$16.5K ﹤0.01% 2952
2023
Q2
$40K Sell
34,444
-108,067
-76% -$193K ﹤0.01% 2986
2023
Q1
$215K Buy
142,511
+11,870
+9% +$29.7K ﹤0.01% 2564
2022
Q4
$327K Sell
130,641
-12,040
-8% -$38.8K ﹤0.01% 2508
2022
Q3
$602K Buy
142,681
+12,112
+9% +$47.4K ﹤0.01% 2243
2022
Q2
$364K Buy
130,569
+7,398
+6% +$29.7K ﹤0.01% 2518
2022
Q1
$705K Sell
123,171
-8,495
-6% -$62.2K ﹤0.01% 2230
2021
Q4
$1.2M Buy
131,666
+2,595
+2% +$26.5K ﹤0.01% 2051
2021
Q3
$1.38M Buy
129,071
+1,677
+1% +$20.4K ﹤0.01% 1944
2021
Q2
$1.98M Sell
127,394
-4,744
-4% -$75.5K ﹤0.01% 1780
2021
Q1
$2.14M Sell
132,138
-348
-0.3% -$6.2K ﹤0.01% 1699
2020
Q4
$2.8M Hold
132,486
﹤0.01% 1445
2020
Q3
$1.96M Buy
132,486
+364
+0.3% +$5.68K ﹤0.01% 1517
2020
Q2
$1.94M Buy
132,122
+4,371
+3% +$71.8K ﹤0.01% 1496
2020
Q1
$1.5M Sell
127,751
-634
-0.5% -$11.9K ﹤0.01% 1468
2019
Q4
$3.02M Buy
128,385
+13,378
+12% +$296K 0.01% 1316
2019
Q3
$2.13M Buy
115,007
+1,376
+1% +$25.3K ﹤0.01% 1492
2019
Q2
$2.11M Buy
113,631
+8,089
+8% +$162K ﹤0.01% 1517
2019
Q1
$2.58M Sell
105,542
-2,346
-2% -$61.4K 0.01% 1362
2018
Q4
$2.8M Buy
107,888
+2,433
+2% +$66.9K 0.01% 1244
2018
Q3
$3.34M Buy
105,455
+7,811
+8% +$291K 0.01% 1291
2018
Q2
$3.79M Buy
97,644
+14,949
+18% +$476K 0.01% 1191
2018
Q1
$2.28M Buy
82,695
+11,082
+15% +$251K ﹤0.01% 1440
2017
Q4
$1.3M Sell
71,613
-998
-1% -$16.3K ﹤0.01% 1851
2017
Q3
$1.17M Sell
72,611
-7,921
-10% -$124K ﹤0.01% 1912
2017
Q2
$1.11M Sell
80,532
-2,000
-2% -$29K ﹤0.01% 1987
2017
Q1
$1.24M Buy
82,532
+17,000
+26% +$235K ﹤0.01% 1945
2016
Q4
$858K Sell
65,532
-1,800
-3% -$28.2K ﹤0.01% 2203
2016
Q3
$1.16M Buy
67,332
+700
+1% +$13K ﹤0.01% 1975
2016
Q2
$1.2M Buy
66,632
+4,732
+8% +$92.4K ﹤0.01% 1926
2016
Q1
$1.18M Buy
61,900
+7,689
+14% +$152K ﹤0.01% 1920
2015
Q4
$1.45M Buy
54,211
+1,000
+2% +$26.7K ﹤0.01% 1764
2015
Q3
$1.3M Buy
53,211
+8,200
+18% +$273K ﹤0.01% 1822
2015
Q2
$1.4M Buy
45,011
+2,523
+6% +$47.5K ﹤0.01% 1885
2015
Q1
$618K Sell
42,488
-500
-1% -$5.64K ﹤0.01% 2318
2014
Q4
$432K Buy
42,988
+184
+0.4% +$1.5K ﹤0.01% 2569
2014
Q3
$357K Buy
42,804
+7,304
+21% +$68K ﹤0.01% 2640
2014
Q2
$437K Buy
+35,500
New +$424K ﹤0.01% 2582

Other funds holding HRTX

California State Teachers Retirement System (CalSTRS)'s HRTX Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Heron Therapeutics (HRTX) stake by 12% in Q1 2026, selling an estimated $1.32K and leaving 8,316 shares worth $6.65K. The position accounts for ﹤0.01% of the portfolio, ranked #2805.

California State Teachers Retirement System (CalSTRS) first reported a position in HRTX in Q2 2014 and has held it in 48 quarters since. The position peaked at $3.79M in Q2 2018. 167 funds tracked by Wall St. Rank hold HRTX as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 8,316 shares of Heron Therapeutics worth $6.65K as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) sold 1,142 Heron Therapeutics shares in Q1 2026, an estimated $1.32K.
  • Heron Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2805 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Heron Therapeutics in Q2 2014 and has held it in 48 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Heron Therapeutics position peaked at $3.79M in Q2 2018.
  • 167 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.